BAVBEK, S. Et Al. 2011. Therapy with omalizumab in patients with severe persistant allergic asthma: real life data in Turkey. (945). European Academy of Allergy and Clinical Immunology (EAACI) 30th Annual Congress , (İstanbul, Turkey), 366.

BAVBEK, S., AYDIN, Ö., KEPİL ÖZDEMİR, S., YILMAZ, İ., ÇELİK, G. E., DEMİREL, Y. S., ... MUNGAN, V. D.(2011). Therapy with omalizumab in patients with severe persistant allergic asthma: real life data in Turkey. (945) . European Academy of Allergy and Clinical Immunology (EAACI) 30th Annual Congress (pp.366). İstanbul, Turkey

BAVBEK, SEVİM Et Al. "Therapy with omalizumab in patients with severe persistant allergic asthma: real life data in Turkey. (945)," European Academy of Allergy and Clinical Immunology (EAACI) 30th Annual Congress, İstanbul, Turkey, 2011

BAVBEK, SEVİM Et Al. "Therapy with omalizumab in patients with severe persistant allergic asthma: real life data in Turkey. (945)." European Academy of Allergy and Clinical Immunology (EAACI) 30th Annual Congress , İstanbul, Turkey, pp.366, 2011

BAVBEK, S. Et Al. (2011) . "Therapy with omalizumab in patients with severe persistant allergic asthma: real life data in Turkey. (945)." European Academy of Allergy and Clinical Immunology (EAACI) 30th Annual Congress , İstanbul, Turkey, p.366.

@conferencepaper{conferencepaper, author={SEVİM BAVBEK Et Al. }, title={Therapy with omalizumab in patients with severe persistant allergic asthma: real life data in Turkey. (945)}, congress name={European Academy of Allergy and Clinical Immunology (EAACI) 30th Annual Congress}, city={İstanbul}, country={Turkey}, year={2011}, pages={366} }